ClinicalTrials.gov
ClinicalTrials.gov Menu

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00126880
Recruitment Status : Completed
First Posted : August 5, 2005
Last Update Posted : June 23, 2011
Sponsor:
Information provided by:
Avexa

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2008
  Actual Study Completion Date : January 2008